Future atherosclerotic cardiovascular disease in systemic lupus erythematosus based on CSTAR (XXVIII): the effect of different antiphospholipid antibodies isotypes
Abstract Background Patients with systemic lupus erythematosus (SLE) suffered from an increasing risk of cardiovascular diseases. In this multi-center prospective study, we aimed to determine the association between antiphospholipid antibodies (aPLs) and future atherosclerotic cardiovascular disease...
Saved in:
| Main Authors: | Can Huang, Yufang Ding, Zhen Chen, Lijun Wu, Wei Wei, Cheng Zhao, Min Yang, Shudian Lin, Qian Wang, Xinping Tian, Jiuliang Zhao, Mengtao Li, Xiaofeng Zeng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | BMC Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12916-024-03843-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mapping Thrombosis Serum Markers by <sup>1</sup>H-NMR Allied with Machine Learning Tools
by: Lucas G. Martins, et al.
Published: (2024-12-01) -
Damage Burden in Polish Patients with Antiphospholipid Syndrome Measured Using Damage Index for Antiphospholipid Syndrome (DIAPS)
by: Ewa Haladyj, et al.
Published: (2025-07-01) -
Pontine Infarct as Initial Presentation of Catastrophic Antiphospholipid Syndrome in Systemic Lupus Erythematous
by: Rathika Rajah, et al.
Published: (2022-07-01) -
Antithrombotic Treatment in Antiphospholipid Syndrome: A Review
by: Carmine Siniscalchi, et al.
Published: (2024-12-01) -
The role of family anamnesis investigation in antiphospholipid syndrome
by: N. N. Chapayeva, et al.
Published: (2009-04-01)